Dear PES members, It is an honor and privilege to start my term as PES President. I want to thank…
Read MoreMore Articles
Brief Therapeutic Update from PES Drugs and Therapeutics Committee Sogroya® (somapactian) Once weekly Sogroya® (somapacitan-beco, Novo Nordisk) was approved by the United States Food and Drug Administration (FDA) for treatment…
Read More
Jessika Weber, DO My name is Jessika, and I am a current 2nd year Pediatric Endocrinology Fellow at the University of Utah in Salt Lake City, UT. I received my…
Read More
Brief Therapeutic Update from PES Drugs and Therapeutics Committee The MiniMed™780G System The MiniMed 780G System from Medtronic was approved by the US Food and Drug Administration on April 21,…
Read More
Historical Tidbit: Hakaru Hashimoto, M.D. (May 4, 1881 to January 9, 1934) and Hashimoto’s Disease Submitted by: Alan D. Rogol, MD, Ph.D. Hakaru Hashimoto was a Japanese doctor and medical…
Read More
Dear PES members and friends, I am still relishing the very successful, first fully independent in-person meeting of the society in San Diego. The great success of this initial meeting…
Read More
Novo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths of Wegovy to wholesalers…
Read More
Naiomi Gunaratne-Breaux, MD I am currently a rising 3rd year fellow in pediatric endocrinology at University of Chicago Medicine Comer Children’s Hospital in Chicago, IL. I received my undergraduate degree…
Read More
Irene Solomon 1932-2022 Irene Solomon (1932-2022) received her undergraduate degree from Radcliffe College and her medical degree from Harvard University (1958). She trained in pediatric endocrinology with Robert Blizzard and…
Read More
Allen O. Whipple, M.D. (Sept 2, 1881 to April 6, 1963) and Whipple’s Triad Submitted by Alan D. Rogol, M.D., Ph.D. Whipple’s triad is a collection of three clinical features…
Read More
Calcium Carbonate (1250mg salt/500mg elemental calcium/5mL) suspension – national shortage. The date of shortage resolution is unknown at this time. For patients on oral therapy, alternatives include: Calcium carbonate tablets…
Read More